Literature DB >> 4654258

Clinical application of 2,5-DI-O-acetyl- -D-gluca ro- (1-4) (6-3)-dilactone (SLA) to the bladder tumor, with special reference to its effect on frequency of tumor recurrences.

T Ichikawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4654258     DOI： 10.1016/s0022-5347(17)60805-x

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C.

Authors:  S Isaka; T Okano; J Shimazaki; T Igarashi; S Murakami; T Higa; T Ishikawa; S Zama; S Kataumi; Z Kataumi
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Recurrence of superficial bladder tumours after transurethral resection.

Authors:  H Fuse; T Sakai; H Kimura; T Katayama
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

3.  A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.

Authors:  Y Hirao; E Okajima; S Ozono; S Samma; K Sasaki; T Hiramatsu; K Babaya; S Watanabe; Y Maruyama
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  Glycosidases in cancer and invasion.

Authors:  R J Bernacki; M J Niedbala; W Korytnyk
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.